ID SUV42_CAEEL Reviewed; 288 AA. AC Q09265; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1997, sequence version 1. DT 27-MAR-2024, entry version 132. DE RecName: Full=Histone-lysine N-methyltransferase Suv4-20; DE EC=2.1.1.362 {ECO:0000255|PROSITE-ProRule:PRU00903, ECO:0000269|PubMed:23028348}; DE AltName: Full=SET domain-containing protein 4; DE AltName: Full=Suppressor of variegation 4-20 homolog; DE Short=Su(var)4-20 homolog; GN Name=set-4; Synonyms=tag-337; ORFNames=C32D5.5; OS Caenorhabditis elegans. OC Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida; OC Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae; OC Caenorhabditis. OX NCBI_TaxID=6239; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=Bristol N2; RX PubMed=9851916; DOI=10.1126/science.282.5396.2012; RG The C. elegans sequencing consortium; RT "Genome sequence of the nematode C. elegans: a platform for investigating RT biology."; RL Science 282:2012-2018(1998). RN [2] RP FUNCTION, AND DISRUPTION PHENOTYPE. RX PubMed=22393255; DOI=10.1128/mcb.06546-11; RA Wells M.B., Snyder M.J., Custer L.M., Csankovszki G.; RT "Caenorhabditis elegans dosage compensation regulates histone H4 chromatin RT state on X chromosomes."; RL Mol. Cell. Biol. 32:1710-1719(2012). RN [3] RP FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND DISRUPTION RP PHENOTYPE. RX PubMed=23028348; DOI=10.1371/journal.pgen.1002933; RA Vielle A., Lang J., Dong Y., Ercan S., Kotwaliwale C., Rechtsteiner A., RA Appert A., Chen Q.B., Dose A., Egelhofer T., Kimura H., Stempor P., RA Dernburg A., Lieb J.D., Strome S., Ahringer J.; RT "H4K20me1 contributes to downregulation of X-linked genes for C. elegans RT dosage compensation."; RL PLoS Genet. 8:E1002933-E1002933(2012). RN [4] RP FUNCTION, AND DISRUPTION PHENOTYPE. RX PubMed=23884442; DOI=10.1242/dev.094292; RA Webster C.M., Wu L., Douglas D., Soukas A.A.; RT "A non-canonical role for the C. elegans dosage compensation complex in RT growth and metabolic regulation downstream of TOR complex 2."; RL Development 140:3601-3612(2013). RN [5] RP FUNCTION, AND DISRUPTION PHENOTYPE. RX PubMed=26641248; DOI=10.1371/journal.pgen.1005698; RA Kramer M., Kranz A.L., Su A., Winterkorn L.H., Albritton S.E., Ercan S.; RT "Developmental dynamics of X-chromosome dosage compensation by the DCC and RT H4K20me1 in C. elegans."; RL PLoS Genet. 11:E1005698-E1005698(2015). CC -!- FUNCTION: Histone methyltransferase that specifically di- and CC trimethylates 'Lys-20' of histone H4 (H4K20me2/me3) (PubMed:22393255, CC PubMed:23028348). H4 'Lys-20' trimethylation represents a specific tag CC for epigenetic transcriptional repression (By similarity). Contributes CC to dosage compensation of X chromosome-relative to autosome-linked gene CC expression, possibly by converting H4K20me1 to H4K20m2/me3 on autosomes CC (PubMed:26641248, PubMed:23028348, PubMed:22393255). Involved in the CC regulation of growth and body fat metabolism downstream of the TOR CC complex 2 pathway (PubMed:23884442). {ECO:0000250|UniProtKB:Q3U8K7, CC ECO:0000269|PubMed:22393255, ECO:0000269|PubMed:23028348, CC ECO:0000269|PubMed:23884442, ECO:0000269|PubMed:26641248}. CC -!- CATALYTIC ACTIVITY: CC Reaction=N(6)-methyl-L-lysyl(20)-[histone H4] + S-adenosyl-L-methionine CC = H(+) + N(6),N(6)-dimethyl-L-lysyl(20)-[histone H4] + S-adenosyl-L- CC homocysteine; Xref=Rhea:RHEA:60348, Rhea:RHEA-COMP:15555, Rhea:RHEA- CC COMP:15556, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, CC ChEBI:CHEBI:61929, ChEBI:CHEBI:61976; EC=2.1.1.362; CC Evidence={ECO:0000255|PROSITE-ProRule:PRU00903, CC ECO:0000269|PubMed:23028348}; CC -!- CATALYTIC ACTIVITY: CC Reaction=N(6),N(6)-dimethyl-L-lysyl(20)-[histone H4] + S-adenosyl-L- CC methionine = H(+) + N(6),N(6),N(6)-trimethyl-L-lysyl(20)-[histone H4] CC + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:61992, Rhea:RHEA- CC COMP:15556, Rhea:RHEA-COMP:15998, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:61961, CC ChEBI:CHEBI:61976; Evidence={ECO:0000255|PROSITE-ProRule:PRU00903, CC ECO:0000269|PubMed:23028348}; CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305|PubMed:23028348}. Chromosome CC {ECO:0000305|PubMed:23028348}. CC -!- DISRUPTION PHENOTYPE: Mutant animals exhibit a lack of di- and CC trimethylation (H4K20me2/me3) and an increase of monomethylation of CC 'Lys-20' (H4K20me1) of histone H4 on autosomes, leading to equal CC H4K20me1 levels on autosomes relative to X chromosomes CC (PubMed:22393255, PubMed:23028348, PubMed:26641248). Decreased CC expression of autosomal genes (PubMed:26641248). Increase in 'Lys-16' CC acetylation of histone H4 (H4K16ac) on hermaphrodite X chromosomes CC (PubMed:22393255). Increase in binding of the RNA Pol II large subunit CC ama-1 on X chromosome gene promoters relative to autosomes CC (PubMed:26641248). In a dpy-21 mutant background, RNAi-mediated CC knockdown leads to embryonic lethality (PubMed:23028348). In the TOR CC complex 2 mutant background rict-1, suppresses the growth delay and CC elevated body fat index (PubMed:23884442). CC {ECO:0000269|PubMed:22393255, ECO:0000269|PubMed:23028348, CC ECO:0000269|PubMed:23884442, ECO:0000269|PubMed:26641248}. CC -!- SIMILARITY: Belongs to the class V-like SAM-binding methyltransferase CC superfamily. Histone-lysine methyltransferase family. Suvar4-20 CC subfamily. {ECO:0000255|PROSITE-ProRule:PRU00903}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; FO080708; CCD66031.1; -; Genomic_DNA. DR PIR; T15735; T15735. DR RefSeq; NP_495272.1; NM_062871.4. DR AlphaFoldDB; Q09265; -. DR SMR; Q09265; -. DR STRING; 6239.C32D5.5.1; -. DR EPD; Q09265; -. DR PaxDb; 6239-C32D5-5; -. DR PeptideAtlas; Q09265; -. DR EnsemblMetazoa; C32D5.5.1; C32D5.5.1; WBGene00016313. DR GeneID; 174045; -. DR KEGG; cel:CELE_C32D5.5; -. DR AGR; WB:WBGene00016313; -. DR WormBase; C32D5.5; CE01845; WBGene00016313; set-4. DR eggNOG; KOG2589; Eukaryota. DR GeneTree; ENSGT00940000173121; -. DR HOGENOM; CLU_040002_1_1_1; -. DR InParanoid; Q09265; -. DR OMA; QGEEITC; -. DR OrthoDB; 5404357at2759; -. DR PhylomeDB; Q09265; -. DR BRENDA; 2.1.1.361; 1045. DR PRO; PR:Q09265; -. DR Proteomes; UP000001940; Chromosome II. DR Bgee; WBGene00016313; Expressed in germ line (C elegans) and 9 other cell types or tissues. DR GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell. DR GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell. DR GO; GO:0140941; F:histone H4K20me methyltransferase activity; IEA:UniProtKB-EC. DR GO; GO:0008340; P:determination of adult lifespan; IMP:UniProtKB. DR GO; GO:0032259; P:methylation; IEA:UniProtKB-KW. DR CDD; cd10524; SET_Suv4-20-like; 1. DR Gene3D; 1.10.10.1700; Histone-lysine N-methyltransferase; 1. DR Gene3D; 2.170.270.10; SET domain; 1. DR InterPro; IPR041938; Hist-Lys_N-MTase_N. DR InterPro; IPR001214; SET_dom. DR InterPro; IPR046341; SET_dom_sf. DR InterPro; IPR039977; Suv4-20/Set9. DR InterPro; IPR025790; Suv4-20_animal. DR PANTHER; PTHR12977:SF4; HISTONE-LYSINE N-METHYLTRANSFERASE KMT5B-RELATED; 1. DR PANTHER; PTHR12977; SUPPRESSOR OF VARIEGATION 4-20-RELATED; 1. DR Pfam; PF00856; SET; 1. DR SMART; SM00317; SET; 1. DR SUPFAM; SSF82199; SET domain; 1. DR PROSITE; PS51570; SAM_MT43_SUVAR420_2; 1. DR PROSITE; PS50280; SET; 1. PE 1: Evidence at protein level; KW Chromatin regulator; Chromosome; Methyltransferase; Nucleus; KW Reference proteome; Repressor; S-adenosyl-L-methionine; Transcription; KW Transcription regulation; Transferase. FT CHAIN 1..288 FT /note="Histone-lysine N-methyltransferase Suv4-20" FT /id="PRO_0000065217" FT DOMAIN 128..238 FT /note="SET" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00190" SQ SEQUENCE 288 AA; 33189 MW; B13A5878E3388EA6 CRC64; MQLHEQIANI SVTFNDIPRS DHSMTPTELC YFDDFATTLV VDSVLNFTTH KMSKKRRYLY QDEYRTARTV MKTFREQRDW TNAIYGLLTL RSVSHFLSKL PPNKLFEFRD HIVRFLNMFI LDSGYTIQEC KRYSQEGHQG AKLVSTGVWS RGDKIERLSG VVCLLSSEDE DSILAQEGSD FSVMYSTRKR CSTLWLGPGA YINHDCRPTC EFVSHGSTAH IRVLRDMVPG DEITCFYGSE FFGPNNIDCE CCTCEKNMNG AFSYLRGNEN AEPIISEKKT KYELRSRS //